Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SPIRONOLACTONE Cause Product substitution issue? 112 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 112 reports of Product substitution issue have been filed in association with SPIRONOLACTONE (spironolactone). This represents 0.5% of all adverse event reports for SPIRONOLACTONE.

112
Reports of Product substitution issue with SPIRONOLACTONE
0.5%
of all SPIRONOLACTONE reports
0
Deaths
12
Hospitalizations

How Dangerous Is Product substitution issue From SPIRONOLACTONE?

Of the 112 reports, 12 (10.7%) required hospitalization, and 5 (4.5%) were considered life-threatening.

Is Product substitution issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SPIRONOLACTONE. However, 112 reports have been filed with the FAERS database.

What Other Side Effects Does SPIRONOLACTONE Cause?

Acute kidney injury (3,273) Hyperkalaemia (2,518) Hypotension (1,583) Dyspnoea (1,468) Drug ineffective (1,379) Hyponatraemia (1,166) Dizziness (991) Fatigue (990) Fall (947) Off label use (899)

What Other Drugs Cause Product substitution issue?

AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (2,832) BUPROPION (1,578) METHYLPHENIDATE (1,408) CLONAZEPAM (1,288) LAMOTRIGINE (979) ALBUTEROL (864) LEVOTHYROXINE (803) DULOXETINE (766) ESTRADIOL (692) SERTRALINE (636)

Which SPIRONOLACTONE Alternatives Have Lower Product substitution issue Risk?

SPIRONOLACTONE vs SPRYCEL SPIRONOLACTONE vs STALEVO SPIRONOLACTONE vs STANNOUS FLUORIDE SPIRONOLACTONE vs STANOZOLOL SPIRONOLACTONE vs STAVUDINE

Related Pages

SPIRONOLACTONE Full Profile All Product substitution issue Reports All Drugs Causing Product substitution issue SPIRONOLACTONE Demographics